Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Alkermes, Inc.
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Has a diagnosis of schizophrenia
Requires acute treatment for symptoms of schizophrenia
Willing and able to be confined to an inpatient study unit for up to 3-4 weeks
Has experienced at least one previous hospitalization for schizophrenia
Has been able to achieve outpatient status for more than 3 months in the past year
Has a body mass index (BMI) between 18.0 and 40.0 kg/m\^2
Resides in a stable living situation when not hospitalized
Has an identified reliable caregiver (for example, family member)
Additional criteria may apply
You may not be if
Poses a current suicide risk
Pregnant, planning to become pregnant, or breastfeeding
Initiated first antipsychotic treatment within the past 12 months
Has received a long-acting injectable antipsychotic in the past 3 months
Has participated in a clinical study involving any investigational product within the past 3 months, or is currently participating in a clinical study involving an investigational product.
A positive urine drug test for drugs of abuse
Additional criteria may apply
Clareo Health | A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
